AccessSync®

A therapy can clear every scientific hurdle; strong trial data, FDA approval, a clinician who believes in it, and still never reach the patient it was created for. That distance, between a drug that works and a patient who receives it, is where market acc

Las Vegas has a way of concentrating your focus. Three days at Asembia 2026 across sessions, hallway conversations, and the expo floor left us with a clear read on where the market access conversation is landing right now.. Here is what stayed with us: Ac

Asembia's AXS26 Summit is a major event for pharma market access teams - with the volume of sessions, exhibitors, and meetings it can be hard to focus on what drives impact. This webinar gives market access, field access, payer marketing, account manageme

Most organizations make a significant investment in market access tools - pre-call planning tools, pull through solutions, data-driven support - to equip field teams with strategic support. Yet it is often a struggle to make these tools matter in the fiel

Learn which market access sessions are offered. Discover exhibitors with a market access focus. Get tips on how to best navigate the conference. Introduction As the Asembia Summit continues to grow and expand its excellent programming, our team has compil

Market access has never been static but in recent years, it has transformed at an unprecedented pace. During Installment 3 of the AccessSync 2026 Webinar Series, Accelerating Market Access: Overcoming Resource Delays, we brought together internal experts

This 30-minute panel discussion will explore the causes, impact, and solutions for market access resource delays-and the significant benefits of getting accurate, timely resources into the hands of your field teams. Learn practical strategies to move fast

Derek Tancredi, AccessSync's Director of Strategy and Insights, explores the current landscape of market access tools, identify gaps in biopharma access digital offerings, and share proven strategies to drive meaningful, long-term field adoption. The webi

A field rep walks into an HCP office prepared to discuss coverage. They reference their platform: the therapy is on formulary, prior authorization isn't required, and the copay is reasonable. But the office manager pauses. "That changed three weeks ago,"

Learn how data lag in internal and external market access feeds can impede field messaging, create credibility risk with HCPs, and reduce pull-through - and how brands are modernizing to accelerate reliable data availability. AccessSync's Tate Rarick, Man